CMS Proposes Permanent Drug Price Negotiation Rules for Medicare

Biden blunders made drug price controls even worse

The comically misnamed Inflation Reduction Act imposed government price controls on prescription drugs by replacing the old non-interference principal, which used market-average prices to set drug reimbursement, with a scheme that allows the Secretary of Health and Human Services to directly set prices via a sham negotiation, in which the manufacturer has to agree or face a punitive seizure via a tax equal to 95% of the product’s total sales. A …

CMS Looks to Crack Down on Medicare Drug Price Negotiation Loophole

Federal health officials last week released a proposal that would codify the federal Medicare Drug Price Negotiation Program (MDPNP) beginning in 2029 and Federal health officials last week released a proposal that would codify the federal Medicare Drug Price Negotiation Program (MDPNP) beginning in 2029 and end a practice that allows drugmakers that modify their products to avoid being subject to negotiation.

CMS Proposes Permanent Drug Price Negotiation Rules for Medicare

WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services has proposed a permanent regulatory framework for Medicare’s Drug Price Negotiation Program, a move that would formalize how the government negotiates prices for high-cost prescription drugs while expanding future negotiations that could affect millions of Medicare beneficiaries. The proposed rule would transition the program from guidance-based implementation to a codified regulato…